PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
10-Aug-2021 PhaseBio Pharmaceuticals and SFJ Pharmaceuticals® Announce Approval of IND Application in China for Bentracimab Businesswire
10-Aug-2021 Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021 Businesswire
10-Aug-2021 Goldfinch Bio Announces Initiation of Open-Label Extension Study for Patients with Focal Segmental Glomerular Sclerosis (FSGS) Enrolled in Phase 2 Clinical Trial of GFB-887 Businesswire
10-Aug-2021 Daniela Drago Joins Aurion Biotech as Chief Regulatory Officer Businesswire
10-Aug-2021 Mylab and US-based Hemex Health Announce Technology Partnership for Point-of-Care Diagnostics for COVID-19 and Other Diseases Businesswire
10-Aug-2021 PhaseBio Pharmaceuticals and SFJ Pharmaceuticals® Announce Approval of IND Application in China for Bentracimab Businesswire
10-Aug-2021 Rootine Is Improving Health Outcomes With Precision Nutrition Businesswire
10-Aug-2021 GreenLight Biosciences Announces Business Agreement With Environmental Impact Acquisition Corp. to Become Publicly Traded Company, Allowing It to Better Harness Its Breakthrough Platform to Develop and Produce RNA for Human Therapies and Agriculture Businesswire
09-Aug-2021 PharmaCyte Biotech Announces Uplist Date to NASDAQ and Pricing of $15 Million Public Offering Businesswire
09-Aug-2021 Electromed, Inc. Announces Select Preliminary Unaudited Financial Results for Fourth Quarter Fiscal 2021 Businesswire
09-Aug-2021 TherapeuticsMD Announces Appointment of Hugh O’Dowd as President Businesswire
09-Aug-2021 Model N Announces Third Quarter Fiscal Year 2021 Financial Results Businesswire
09-Aug-2021 Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate Update Businesswire
09-Aug-2021 QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements Businesswire
09-Aug-2021 Fulgent Genetics Reports Second Quarter Financial Results Businesswire
09-Aug-2021 Athersys Reports Second Quarter 2021 Results Businesswire
09-Aug-2021 Atara Biotherapeutics Announces Second Quarter 2021 Financial Results and Operational Progress Businesswire
09-Aug-2021 Fulgent Genetics and Helio Health Announce Strategic Partnership to Commercialize Early Cancer Detection Tests Businesswire
09-Aug-2021 Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress Businesswire
09-Aug-2021 Atara Biotherapeutics Appoints Cell Therapy and Oncology Commercialization Veteran Ameet Mallik to the Board of Directors Businesswire